106 related articles for article (PubMed ID: 28762267)
41. Optimization of Tet1 ligand density in HPMA-co-oligolysine copolymers for targeted neuronal gene delivery.
Chu DS; Schellinger JG; Bocek MJ; Johnson RN; Pun SH
Biomaterials; 2013 Dec; 34(37):9632-7. PubMed ID: 24041424
[TBL] [Abstract][Full Text] [Related]
42. GRP78-Targeted HPMA Copolymer-Photosensitizer Conjugate for Hyperthermia-Induced Enhanced Uptake and Cytotoxicity in MCF-7 Breast Cancer Cells.
Battogtokh G; Gotov O; Subrahmanyam N; Ko YT; Ghandehari H
Macromol Biosci; 2019 Jul; 19(7):e1900032. PubMed ID: 31141313
[TBL] [Abstract][Full Text] [Related]
43. Synthetic macromolecular drug carriers: biodistribution of poly[(N-2-hydroxypropyl)methacrylamide] copolymers and their accumulation in solid rat tumors.
Kissel M; Peschke P; Subr V; Ulbrich K; Schuhmacher J; Debus J; Friedrich E
PDA J Pharm Sci Technol; 2001; 55(3):191-201. PubMed ID: 11417110
[TBL] [Abstract][Full Text] [Related]
44. PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination.
Satchi-Fainaro R; Hailu H; Davies JW; Summerford C; Duncan R
Bioconjug Chem; 2003; 14(4):797-804. PubMed ID: 12862433
[TBL] [Abstract][Full Text] [Related]
45. Tumor targeting HPMA-porphyrin-99mTc copolymer molecular imaging agent.
Yuan L; Ma Y; Yuan J
J Biomater Sci Polym Ed; 2014; 25(18):2066-79. PubMed ID: 25315509
[TBL] [Abstract][Full Text] [Related]
46. PEGylation of HPMA-based block copolymers enhances tumor accumulation in vivo: a quantitative study using radiolabeling and positron emission tomography.
Allmeroth M; Moderegger D; Gündel D; Buchholz HG; Mohr N; Koynov K; Rösch F; Thews O; Zentel R
J Control Release; 2013 Nov; 172(1):77-85. PubMed ID: 23954630
[TBL] [Abstract][Full Text] [Related]
47. The influence of gradient and statistical arrangements of guanidinium or primary amine groups in poly(methacrylate) copolymers on their DNA binding affinity.
Tabujew I; Cokca C; Zartner L; Schubert US; Nischang I; Fischer D; Peneva K
J Mater Chem B; 2019 Oct; 7(39):5920-5929. PubMed ID: 31538170
[TBL] [Abstract][Full Text] [Related]
48. The influence of linker length on the properties of cathepsin S cleavable (177)Lu-labeled HPMA copolymers for pancreatic cancer imaging.
Shi W; Ogbomo SM; Wagh NK; Zhou Z; Jia Y; Brusnahan SK; Garrison JC
Biomaterials; 2014 Jul; 35(22):5760-70. PubMed ID: 24755528
[TBL] [Abstract][Full Text] [Related]
49. Targeting Intratibial Osteosarcoma Using Water-Soluble Copolymers Conjugated to Collagen Hybridizing Peptides.
Subrahmanyam N; Yathavan B; Yu SM; Ghandehari H
Mol Pharm; 2023 Mar; 20(3):1670-1680. PubMed ID: 36724294
[TBL] [Abstract][Full Text] [Related]
50. Copolymers of 2-methacryloyloxyethyl phosphorylcholine (MPC) as biomaterials.
Nakabayashi N; Iwasaki Y
Biomed Mater Eng; 2004; 14(4):345-54. PubMed ID: 15472384
[TBL] [Abstract][Full Text] [Related]
51. HPMA-Copolymer Nanocarrier Targets Tumor-Associated Macrophages in Primary and Metastatic Breast Cancer.
Zimel MN; Horowitz CB; Rajasekhar VK; Christ AB; Wei X; Wu J; Wojnarowicz PM; Wang D; Goldring SR; Purdue PE; Healey JH
Mol Cancer Ther; 2017 Dec; 16(12):2701-2710. PubMed ID: 28830983
[TBL] [Abstract][Full Text] [Related]
52. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release.
Etrych T; Sírová M; Starovoytova L; Ríhová B; Ulbrich K
Mol Pharm; 2010 Aug; 7(4):1015-26. PubMed ID: 20518512
[TBL] [Abstract][Full Text] [Related]
53. Construction of Gambogic Acid HPMA Copolymer Coupling Drug System and Study on Anti-tumor Activity.
Zhao X; Ding S; Li S; Wang Y; Jiang M; Liu J; Chen Y
Curr Drug Deliv; 2022; 19(4):491-507. PubMed ID: 34325635
[TBL] [Abstract][Full Text] [Related]
54. Langmuir-Blodgett films of biocompatible poly(HPMA)-block-poly(lauryl methacrylate) and poly(HPMA)-random-poly(lauryl methacrylate): influence of polymer structure on membrane formation and stability.
Scheibe P; Barz M; Hemmelmann M; Zentel R
Langmuir; 2010 Apr; 26(8):5661-9. PubMed ID: 20345113
[TBL] [Abstract][Full Text] [Related]
55. Amphiphilic HPMA-LMA copolymers increase the transport of Rhodamine 123 across a BBB model without harming its barrier integrity.
Hemmelmann M; Metz VV; Koynov K; Blank K; Postina R; Zentel R
J Control Release; 2012 Oct; 163(2):170-7. PubMed ID: 22981565
[TBL] [Abstract][Full Text] [Related]
56. Dual-pH Sensitive Charge-reversal Nanocomplex for Tumor-targeted Drug Delivery with Enhanced Anticancer Activity.
Zhou Q; Hou Y; Zhang L; Wang J; Qiao Y; Guo S; Fan L; Yang T; Zhu L; Wu H
Theranostics; 2017; 7(7):1806-1819. PubMed ID: 28638469
[TBL] [Abstract][Full Text] [Related]
57. Polymeric conjugates of mono- and bi-cyclic alphaVbeta3 binding peptides for tumor targeting.
Mitra A; Coleman T; Borgman M; Nan A; Ghandehari H; Line BR
J Control Release; 2006 Aug; 114(2):175-83. PubMed ID: 16889865
[TBL] [Abstract][Full Text] [Related]
58. Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systems.
Lammers T; Peschke P; Kühnlein R; Subr V; Ulbrich K; Debus J; Huber P; Hennink W; Storm G
J Control Release; 2007 Feb; 117(3):333-41. PubMed ID: 17215057
[TBL] [Abstract][Full Text] [Related]
59. Galactosylated 2-hydroxypropyl methacrylamide-s-3-guanidinopropyl methacrylamide copolymer as a small hairpin RNA carrier for inhibiting human telomerase reverse transcriptase expression.
Wu Y; Ji J; Yang R; Zhang X; Li Y; Pu Y; Li X
J Gene Med; 2014; 16(5-6):109-21. PubMed ID: 24981025
[TBL] [Abstract][Full Text] [Related]
60. HPMA copolymers as surfactants in the preparation of biocompatible nanoparticles for biomedical application.
Kelsch A; Tomcin S; Rausch K; Barz M; Mailänder V; Schmidt M; Landfester K; Zentel R
Biomacromolecules; 2012 Dec; 13(12):4179-87. PubMed ID: 23181390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
